In this context, it is interesting to note that Zaroff and colleagues recently reported under-expression of NAT8L as well as NAA levels in a transgenic mouse model of AD, even in the absence of significant neuronal loss [81]. This evidence concerns the gene ASPNAT and Alzheimer disease.